drugset / Trial / NCT01845038
Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate how OTX-TP, a sustained release travoprost drug product, when placed in the canaliculus of the eyelid compares to timolol drops for the lowering of intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-03
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |
| Subject | Travoprost | Other / unclassified | 3 ug | Other |
| Subject | Travoprost | Other / unclassified | 4 ug | Other |